The ambulatory iv infusion pumps market size has grown steadily in recent years. It will grow from $0.91 billion in 2025 to $0.95 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to growth in outpatient treatment models, increasing prevalence of chronic diseases, early adoption of ambulatory infusion technologies, expansion of home healthcare services, improvements in pump safety mechanisms.
The ambulatory iv infusion pumps market size is expected to see steady growth in the next few years. It will grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing demand for remote therapy management, rising integration of connected healthcare devices, expansion of personalized drug delivery solutions, growing focus on reducing hospital stays, advancements in battery efficiency and pump miniaturization. Major trends in the forecast period include increasing adoption of portable and wearable infusion pumps, rising demand for home-based infusion therapies, growing integration of smart dose monitoring features, expansion of multi-therapy pump applications, enhanced focus on patient mobility and comfort.
The rising number of surgical procedures is expected to drive the growth of the ambulatory IV infusion pumps market. Surgical procedures involve medical interventions that require incisions or invasive techniques to access and treat internal or external areas of the body. Ambulatory IV infusion pumps provide controlled administration of fluids, medications, and anesthetics during these procedures, ensuring precise and continuous delivery, which enhances patient safety and surgical efficiency. For instance, in July 2025, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and aesthetic practices, cosmetic procedure volumes increased by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. This rise in surgical procedures is driving demand for ambulatory IV infusion pumps.
Major companies in the ambulatory IV infusion pumps market are focusing on innovations such as precision infusion pumps to improve accuracy, consistency, and data reliability in infusion therapy. Precision infusion pumps are advanced devices designed to deliver medications and fluids with highly controlled accuracy while minimizing variability under different clinical conditions. For instance, in April 2025, ICU Medical, a US-based manufacturer of medical infusion technologies, launched the Plum Solo and Plum Duo precision IV pumps. These devices feature high-accuracy delivery mechanisms supported by integrated digital functions to improve infusion consistency, regardless of environmental or setup factors. The pumps expand a unified infusion platform that strengthens medication management, supports full electronic health record interoperability, and provides clinicians with more reliable real-time infusion data.
In May 2025, ICU Medical, a US-based provider of infusion therapy systems and ambulatory IV infusion pumps, partnered with Otsuka Pharmaceutical Factory, Inc. to enhance IV solutions manufacturing capacity and innovation in North America. The partnership aims to improve supply chain resiliency and introduce advanced PVC-free IV solution technologies to better support healthcare providers. Otsuka Pharmaceutical Factory, Inc. is a Japan-based company specializing in clinical nutrition products and IV solutions produced across its global manufacturing network.
Major companies operating in the ambulatory iv infusion pumps market are Baxter International Inc, Becton Dickinson and Company, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc, Medtronic plc, Mindray Medical International Limited, Nipro Corporation, Moog Inc, Zyno Medical LLC, Micrel Medical Devices SA, JMS Co Ltd, Eitan Medical, SOOIL Development Co Ltd, Ypsomed Holding AG, Arcomed AG, Comen Medical, Flowonix Medical, Akas Infusion, CME Medical.
North America was the largest region in the ambulatory IV infusion pumps market in 2025. Western Europe was the second largest region in the global ambulatory IV infusion pump market. The regions covered in the ambulatory iv infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ambulatory iv infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ambulatory iv infusion pumps market by increasing costs of imported sensors, microcontrollers, motors, batteries, and precision plastic components. Device manufacturers in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces higher export-related costs. These tariffs are increasing device prices and slowing adoption in home healthcare settings. However, they are also encouraging domestic assembly, localized component sourcing, and innovation in simplified and cost-optimized pump designs.
The ambulatory iv infusion pumps market research report is one of a series of new reports that provides ambulatory iv infusion pumps market statistics, including ambulatory iv infusion pumps industry global market size, regional shares, competitors with a ambulatory iv infusion pumps market share, detailed ambulatory iv infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory iv infusion pumps industry. This ambulatory iv infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ambulatory IV infusion pumps are portable medical devices designed for the controlled delivery of medication into the patient's body.
The ambulatory IV infusion pumps market, as covered in this report, is segmented by type into disposable infusion pumps and chemotherapy infusion pumps. Disposable infusion pumps are single-use devices utilized for the controlled delivery of medication into the patient's body. These pumps find applications in various medical fields such as chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other medical applications. These devices are employed by a range of end-users including hospitals, home healthcare, and others.
The ambulatory IV infusion pumps market consists of sales of disposable infusion pumps and chemotherapy infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The ambulatory iv infusion pumps market size is expected to see steady growth in the next few years. It will grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to increasing demand for remote therapy management, rising integration of connected healthcare devices, expansion of personalized drug delivery solutions, growing focus on reducing hospital stays, advancements in battery efficiency and pump miniaturization. Major trends in the forecast period include increasing adoption of portable and wearable infusion pumps, rising demand for home-based infusion therapies, growing integration of smart dose monitoring features, expansion of multi-therapy pump applications, enhanced focus on patient mobility and comfort.
The rising number of surgical procedures is expected to drive the growth of the ambulatory IV infusion pumps market. Surgical procedures involve medical interventions that require incisions or invasive techniques to access and treat internal or external areas of the body. Ambulatory IV infusion pumps provide controlled administration of fluids, medications, and anesthetics during these procedures, ensuring precise and continuous delivery, which enhances patient safety and surgical efficiency. For instance, in July 2025, according to the American Med Spa Association, a US-based provider of legal, compliance, and business resources for medical spas and aesthetic practices, cosmetic procedure volumes increased by 42.5% over the past four years, reaching 20.5 million non-surgical treatments and 17.4 million surgical procedures in 2024. This rise in surgical procedures is driving demand for ambulatory IV infusion pumps.
Major companies in the ambulatory IV infusion pumps market are focusing on innovations such as precision infusion pumps to improve accuracy, consistency, and data reliability in infusion therapy. Precision infusion pumps are advanced devices designed to deliver medications and fluids with highly controlled accuracy while minimizing variability under different clinical conditions. For instance, in April 2025, ICU Medical, a US-based manufacturer of medical infusion technologies, launched the Plum Solo and Plum Duo precision IV pumps. These devices feature high-accuracy delivery mechanisms supported by integrated digital functions to improve infusion consistency, regardless of environmental or setup factors. The pumps expand a unified infusion platform that strengthens medication management, supports full electronic health record interoperability, and provides clinicians with more reliable real-time infusion data.
In May 2025, ICU Medical, a US-based provider of infusion therapy systems and ambulatory IV infusion pumps, partnered with Otsuka Pharmaceutical Factory, Inc. to enhance IV solutions manufacturing capacity and innovation in North America. The partnership aims to improve supply chain resiliency and introduce advanced PVC-free IV solution technologies to better support healthcare providers. Otsuka Pharmaceutical Factory, Inc. is a Japan-based company specializing in clinical nutrition products and IV solutions produced across its global manufacturing network.
Major companies operating in the ambulatory iv infusion pumps market are Baxter International Inc, Becton Dickinson and Company, B. Braun Melsungen AG, Fresenius Kabi AG, ICU Medical Inc, Medtronic plc, Mindray Medical International Limited, Nipro Corporation, Moog Inc, Zyno Medical LLC, Micrel Medical Devices SA, JMS Co Ltd, Eitan Medical, SOOIL Development Co Ltd, Ypsomed Holding AG, Arcomed AG, Comen Medical, Flowonix Medical, Akas Infusion, CME Medical.
North America was the largest region in the ambulatory IV infusion pumps market in 2025. Western Europe was the second largest region in the global ambulatory IV infusion pump market. The regions covered in the ambulatory iv infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ambulatory iv infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the ambulatory iv infusion pumps market by increasing costs of imported sensors, microcontrollers, motors, batteries, and precision plastic components. Device manufacturers in North America and Europe are most affected due to reliance on imported electronics, while Asia-Pacific faces higher export-related costs. These tariffs are increasing device prices and slowing adoption in home healthcare settings. However, they are also encouraging domestic assembly, localized component sourcing, and innovation in simplified and cost-optimized pump designs.
The ambulatory iv infusion pumps market research report is one of a series of new reports that provides ambulatory iv infusion pumps market statistics, including ambulatory iv infusion pumps industry global market size, regional shares, competitors with a ambulatory iv infusion pumps market share, detailed ambulatory iv infusion pumps market segments, market trends and opportunities, and any further data you may need to thrive in the ambulatory iv infusion pumps industry. This ambulatory iv infusion pumps market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ambulatory IV infusion pumps are portable medical devices designed for the controlled delivery of medication into the patient's body.
The ambulatory IV infusion pumps market, as covered in this report, is segmented by type into disposable infusion pumps and chemotherapy infusion pumps. Disposable infusion pumps are single-use devices utilized for the controlled delivery of medication into the patient's body. These pumps find applications in various medical fields such as chemotherapy/oncology, diabetes, gastroenterology, analgesia/pain management, pediatrics/neonatology, hematology, and other medical applications. These devices are employed by a range of end-users including hospitals, home healthcare, and others.
The ambulatory IV infusion pumps market consists of sales of disposable infusion pumps and chemotherapy infusion pumps. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ambulatory IV infusion Pumps Market Characteristics
3. Ambulatory IV infusion Pumps Market Supply Chain Analysis
4. Global Ambulatory IV infusion Pumps Market Trends and Strategies
5. Ambulatory IV infusion Pumps Market Analysis of End Use Industries
7. Global Ambulatory IV infusion Pumps Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ambulatory IV infusion Pumps Total Addressable Market (TAM) Analysis for the Market
9. Ambulatory IV infusion Pumps Market Segmentation
10. Ambulatory IV infusion Pumps Market Regional and Country Analysis
11. Asia-Pacific Ambulatory IV infusion Pumps Market
12. China Ambulatory IV infusion Pumps Market
13. India Ambulatory IV infusion Pumps Market
14. Japan Ambulatory IV infusion Pumps Market
15. Australia Ambulatory IV infusion Pumps Market
16. Indonesia Ambulatory IV infusion Pumps Market
17. South Korea Ambulatory IV infusion Pumps Market
18. Taiwan Ambulatory IV infusion Pumps Market
19. South East Asia Ambulatory IV infusion Pumps Market
20. Western Europe Ambulatory IV infusion Pumps Market
21. UK Ambulatory IV infusion Pumps Market
22. Germany Ambulatory IV infusion Pumps Market
23. France Ambulatory IV infusion Pumps Market
24. Italy Ambulatory IV infusion Pumps Market
25. Spain Ambulatory IV infusion Pumps Market
26. Eastern Europe Ambulatory IV infusion Pumps Market
27. Russia Ambulatory IV infusion Pumps Market
28. North America Ambulatory IV infusion Pumps Market
29. USA Ambulatory IV infusion Pumps Market
30. Canada Ambulatory IV infusion Pumps Market
31. South America Ambulatory IV infusion Pumps Market
32. Brazil Ambulatory IV infusion Pumps Market
33. Middle East Ambulatory IV infusion Pumps Market
34. Africa Ambulatory IV infusion Pumps Market
36. Ambulatory IV infusion Pumps Market Competitive Landscape and Company Profiles
37. Ambulatory IV infusion Pumps Market Other Major and Innovative Companies
40. Ambulatory IV infusion Pumps Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Ambulatory IV infusion Pumps Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ambulatory iv infusion pumps market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ambulatory iv infusion pumps? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ambulatory iv infusion pumps market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Therapy: Chemotherapy Infusion Pumps; Anti-Infective Infusion Pumps; Other Therapies2) By Application: Chemotherapy Or Oncology; Diabetes, Gastroenterology; Analgesia Or Pain Management; Pediatrics Or Neonatology; Hematology; Anti-Infective; Other Applications
3) By Patient Care Setting: Hospitals; Home Healthcare; Other End Users
Subsegments:
1) By Chemotherapy Infusion Pumps: Continuous Chemotherapy Infusion Pumps; Cyclic Chemotherapy Infusion Pumps; Patient-Controlled Analgesia (PCA) Pumps for Chemotherapy2) By Anti-Infective Infusion Pumps: Antibiotic Infusion Pumps; Antiviral Infusion Pumps; Antifungal Infusion Pumps
3) By Other Therapies: Pain Management Infusion Pumps; Nutritional Infusion Pumps (Total Parenteral Nutrition); Hormonal Therapy Infusion Pumps; Hydration Infusion Pumps
Companies Mentioned: Baxter International Inc; Becton Dickinson and Company; B. Braun Melsungen AG; Fresenius Kabi AG; ICU Medical Inc; Medtronic plc; Mindray Medical International Limited; Nipro Corporation; Moog Inc; Zyno Medical LLC; Micrel Medical Devices SA; JMS Co Ltd; Eitan Medical; SOOIL Development Co Ltd; Ypsomed Holding AG; Arcomed AG; Comen Medical; Flowonix Medical; Akas Infusion; CME Medical
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ambulatory IV infusion Pumps market report include:- Baxter International Inc
- Becton Dickinson and Company
- B. Braun Melsungen AG
- Fresenius Kabi AG
- ICU Medical Inc
- Medtronic plc
- Mindray Medical International Limited
- Nipro Corporation
- Moog Inc
- Zyno Medical LLC
- Micrel Medical Devices SA
- JMS Co Ltd
- Eitan Medical
- SOOIL Development Co Ltd
- Ypsomed Holding AG
- Arcomed AG
- Comen Medical
- Flowonix Medical
- Akas Infusion
- CME Medical
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.95 Billion |
| Forecasted Market Value ( USD | $ 1.15 Billion |
| Compound Annual Growth Rate | 4.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
